The Attractiveness of Investing In Prestige Consumer Healthcare Inc (PBH) is Growing

Prestige Consumer Healthcare Inc’s recent filing unveils that its SVP Quality & Regulatory Fritz Mary Beth unloaded Company’s shares for reported $12112.0 on Mar 01 ’24. In the deal valued at $70.42 per share,172 shares were sold. As a result of this transaction, Fritz Mary Beth now holds 15,934 shares worth roughly $1.18 million.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Then, Fritz Mary Beth sold 662 shares, generating $46,536 in total proceeds. Upon selling the shares at $70.30, the SVP Quality & Regulatory now owns 15,934 shares.

Before that, Fritz Mary Beth sold 1 shares. Prestige Consumer Healthcare Inc shares valued at $70 were divested by the SVP Quality & Regulatory at a price of $70.00 per share. As a result of the transaction, Fritz Mary Beth now holds 15,934 shares, worth roughly $1.18 million.

Canaccord Genuity initiated its Prestige Consumer Healthcare Inc [PBH] rating to a Buy in a research note published on November 17, 2022; the price target was $71. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early May from “a Hold” to “a Buy”. Oppenheimer also remained covering PBH and has increased its forecast on May 09, 2022 with a “an Outperform” recommendation from previously “Perform” rating. DA Davidson revised its rating on August 07, 2020. It rated PBH as “a Neutral” which previously was an “a Buy”.

Price Performance Review of PBH

On Tuesday, Prestige Consumer Healthcare Inc [NYSE:PBH] saw its stock fall -0.58% to $74.15. Over the last five days, the stock has gained 4.08%. Prestige Consumer Healthcare Inc shares have risen nearly 21.12% since the year began. Nevertheless, the stocks have risen 25.21% over the past one year. While a 52-week high of $75.08 was reached on 03/11/24, a 52-week low of $52.90 was recorded on 01/05/24. SMA at 50 days reached $65.19, while 200 days put it at $60.95. A total of 0.46 million shares were traded, compared to the trading of 0.25 million shares in the previous session.

Levels Of Support And Resistance For PBH Stock

The 24-hour chart illustrates a support level at 73.68, which if violated will result in even more drops to 73.20. On the upside, there is a resistance level at 74.72. A further resistance level may holdings at 75.28. The Relative Strength Index (RSI) on the 14-day chart is 75.86, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.86, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.49%. Stochastics %K at 91.55% indicates the stock is a selling.

How much short interest is there in Prestige Consumer Healthcare Inc?

A steep rise in short interest was recorded in Prestige Consumer Healthcare Inc stocks on Feb 29, 2024, growing by 10000.0 shares to a total of 1.73 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 1.72 million shares. There was a rise of 0.58%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.86% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.66.

Most Popular